Faculty - YAMAMOTO Yukiya |

（Last updated : 2025-06-03 12:52:26）

YAMAMOTO Yukiya

Department / Course

College of Life and Health Sciences Department of Biomedical Sciences

Office for the Coordination of Clinical Practicums Center for Clinical Examination Practicum Support

Graduate School of Life and Health Sciences Department of Biomedical Sciences

Job Professor

Academic background
1998/04～2002/03	graduate school of medicine Nagoya University
1987/04～1993/03	School of Medicine Nagoya University

Business career
2020/04 ～	Chubu University College of Life and Health Sciences, Department of Biomedical Sciences
2020/03 ～	Fujita Health University Hospital Hematology & Chemotherapy
2020/03 ～	Fujita Health University Department of Medicine
2018/10 ～ 2020/03	Fujita Health University Hematology
2017/04 ～ 2018/10	Fujita Health University Hematology
Display All（9）

Belonging society
	THE JAPANESE SOCIETY OF INTERNAL MEDICINE
	THE JAPANESE CANCER ASSOCIATION
	THE JAPANESE SOCIETY OF HEMATOLOGY
	American Society of Hematology

Present specialized field
Molecular biology, Tumor diagnostics and therapeutics, Hematology and medical oncology keyword(gene mutations,chromosomal translocation,disease models,kinase inhibitors,MPN,signal transduction,AML,transcription factors,tumor supressor,APL,phage library,therapeutic antibody)

Research, Studies
Hematology and Oncology

Book and thesis
Papers	ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation Leukemia (Co-authored) 2025/01
Papers	Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate its Safety, Pharmacokinetics, and Pharmacodynamics Clinical Pharmacology in Drug Development,pp.579-587 2023/06
Papers	PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development Communications Biology 5 (1),pp.961 2022/09/14
Papers	A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1) International Journal of Hematology 116,pp.956-960 2022/07/19
Papers	CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma Blood Advances 6 (11),pp.3230-3233 2022/06/14
Display All（81）

Academic conference presentation
2021/09/25	A novel fusion transcript RARA-SNX15 in an APL case harboring t(11;17;15)(q13;q21.2;q24.1)
2020/10/09	ARID1B-EMID1 fusion in BCR-ABL1 positive chronic myeloid leukemia with t(6;9 ;22)(q25;q34;q11.2)
2019/10/11	CD4+CD56+ blastic NK cell leukemia with TCF4-MAML3 fusion gene
2015/12/05	Elongation of MPL transmembrane domain is a novel activating-mutation in essential thrombocythemia (57th ASH Annual Meeting & Exposition)
2015/10/16	Elongation of MPL transmembrane domain is a novel activating-mutation in essential thrombocythemia (The 77th Annual Meeting of the Japanese Society of Hematology)
Display All（9）

Lecturer and lecture
2022/12/02	Diagnosis and treatment of essential thrombocythemia

Research topic, funded research, and department laboratory expense
2011/04/28 ～ 2015/03/31	Leukemogenic property of acute promyelocytic leukemia gene, BCOR-RARA Grant-in-Aid for Scientific Research (C)

Winning science prize
2008/11	Medical Research Fellowship of Takeda Science Foundation
2003/11	KYO Award of Japanese Leukaemia Research Fund

Teaching Experiences
Introduction to disease treatment （Chubu University）
Disease Pathology Overview （Chubu University）
General medicine （Fujita Health University）
Clinical Pathology （Chubu University）
Clinical Hematology （Chubu University）
Display All（6）

Activity in society
2023/08/05 ～	PLOS ONE Editorial Board member
2019/10/11 ～ 2019/10/13	chairman

Committee and society
2020/08 ～	Perseus Proteomics Inc. Medical Expert
2017/11 ～	MPN-JAPAN Medical Expert
2016/09 ～	Japanese Society of Hematology Councilor